IMMUNOHISTOCHEMICAL DETERMINATION OF EXPRESSION OF SOMATOSTATIN RECEPTORS TYPES 1, 2A, 3 AND 5 IN NEUROENDOCRINE TUMORS OF VARIOUS LOCALIZATION AND GRADE

Background: Prediction of clinical benefits of somatostatin analogues in patients with neuroendocrine tumors (NET) is very important prior to their administration. Data on immunohistochemical assessment of the expression of somatostatin receptors (SSR) of various types, obtained from large samples o...

Full description

Bibliographic Details
Main Authors: L. E. Gurevich, N. A. Korsakova, I. A. Voronkova, V. E. Ashevskaya, A. G. Titov, L. M. Kogoniya, A. V. Egorov, T. A. Britvin, I. A. Vasil'ev
Format: Article
Language:Russian
Published: MONIKI 2016-12-01
Series:Alʹmanah Kliničeskoj Mediciny
Subjects:
Online Access:https://www.almclinmed.ru/jour/article/view/427